BIB offers technical process development service for the production of recombinant proteins, viral vaccines, and gene therapies using microbial or cell cultures. We focus on developing and deploying reproducible, robust, scalable, and manufacturing-friendly upstream processes.
We offer the following services:
We provide a full spectrum services which utilize next generation technologies, QbD and DoE methodologies. Our experienced scientists deliver the highest quality project results in a timely and efficient manner. We pride ourselves in achieving milestones for our customers with a focused mindset on commercialization.
We provide strain development and cell line development services with State-of-the-art facilities and high throughput technologies to support our clients with accurate and high standard of quality.
© 2023 Boston Institute of Biotechnology. All rights reserved.
